Evelo Biosciences Target of Unusually High Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw some unusual options trading on Wednesday. Stock investors bought 1,885 put options on the company. This represents an increase of 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Price Performance

The stock’s fifty day moving average price is $0.03 and its 200-day moving average price is $0.04. Evelo Biosciences has a 52-week low of $0.00 and a 52-week high of $4.28. The firm has a market capitalization of $2,000.00, a PE ratio of 0.00 and a beta of 1.59.

Evelo Biosciences Company Profile

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.